Further testing for mutations in the GRHPR (PH II) and the HOGA1 gene (PH III) was performed in the other four patients, although neither urinary glyceric acid, nor hydroxy-oxo-glutarate was elevated in any of the patients. The gene discussed is HOGA1; the disease is primary hyperoxaluria type 3.